ORBIMED ADVISORS LLC - Dec 31, 2024 SCHEDULE 13G Report for ADC Therapeutics SA (ADCT)

Filing Manager: ORBIMED ADVISORS LLC
Reporting Manager: ORBIMED CAPITAL LLC
Security: ADC Therapeutics SA Common Shares, par value CHF 0.08 per share
Symbol: ADCT
Shares outstanding: 95.5M shares
Disclosed Ownership: 3.44M shares
Ownership: 3.6%
Form type: SCHEDULE 13G
Date filed: 2/14/2025, 04:35 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ORBIMED ADVISORS LLC	2.6%	2.53M	0	2.53M	/s/ Carl L. Gordon	Carl L. Gordon/Member
ORBIMED CAPITAL LLC	3.6%	3.44M	3.44M	0	/s/ Carl L. Gordon	Carl L. Gordon/Member

Showing 1 to 2 of 2 entries